STI clinic visits and Chlamydia/Gonorrhea testing have not returned to pre-COVID levels, five U.S. jurisdictions, 2018-2022.

We evaluated whether sexually transmitted infection (STI) clinic visits and chlamydia/gonorrhea tests in five jurisdictions had returned to pre-COVID levels by 2022. Patient volume and chlamydia/gonorrhea testing have not returned to pre-COVID levels, especially among people <30 years.